IP & licensing agreements

IP & licensing agreements

"Light years ahead of any other IP Lawyers we have ever worked with."

CEO, Liverpool Sound City

A dedicated, knowledgeable and enthusiastic team of specialists with technical expertise in Intellectual Property and Licensing.

Shoosmiths' IP and licensing team offers diverse specialists with the breadth to offer clients the very best advice across the business spectrum. The IP and licensing team offers clients a refreshingly commercial approach to the identification, protection, exploitation and defence of intellectual property rights.

Our experience and industry knowledge separates us from the competition. Our technical capability covers areas such as music, digital, publishing, fashion, branding and design.

The majority of our lawyers have worked in-house, meaning they can offer complex, strategic and business critical advice that is both commercially realistic and legally sound to add real value to your business.

Our team regularly advises multi-national companies, as well as start-ups and spin-outs, on a broad spectrum of IP issues, such as:

Brands and marketing

  • trade mark licences
  • sponsorship agreements
  • image rights agreements
  • affinity agreements

Innovation and technology transfer

  • collaboration agreements
  • research and development agreements
  • patent licences
  • knowledge-transfer agreements

Publishing and content

  • author-publisher agreements
  • editor-publisher agreements
  • content licensing agreements
  • e-book agreements

Our clients include: Associated British Foods (which owns brands such as Blue Dragon, Jordans, Kingsmill, Ovaltine, Ryvita and Twinings), AstraZeneca, Castle Galleries, Cambridge University Press, Informa Business Information, Macmillan Publishing, Science in Sport (SiS), Taylor & Francis, The Open University and Volkswagen Group (Audi, Seat, Skoda and Volkswagen).

Our team is regularly ranked as a Tier 1 practice by both the Chambers and Legal 500 directories.

Work Highlights

  • Advising FTSE 100 pharmaceutical company on a multi-billion pound research and development project for the treatment of the diseases that affect the Central Nervous System.
  • Advising one of the "Big 5" publishing houses on its portfolio of e-Book agreements.
  • Advising major UK travel company on its high-profile sponsorship deal with a Premiership football team.